Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137826
Status:
COMPLETED
Last Update Posted:
2011-12-26
First Post:
2005-08-29
Brief Title:
Bevacizumab Avastin and Erlotinib Tarceva in Previously Treated Mesothelioma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-29
First Submit QC Date:
August 29 2005
Study First Post Date:
2005-08-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-23
Last Update Post Date:
2011-12-26
Last Update Post Date Type:
ESTIMATED